Company / Free Cash Flow
ARS Pharmaceuticals, Inc. Free Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$171.2M
FY2025
5-year range
-$171.2M / $13.0M
FY2021-FY2025
Trend
-1418.5%
vs FY2024
Sector context
#138 of 194
Health Care
What the data says
Free Cash Flow changed -1418% YoY in FY2025, a notable deviation from the 5-year average annual change of -298%.
Based on SEC 10-K filings.
-$171M in FY2025.
Declined from -$59M to -$171M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#138 of 194 in Health CareTop 71% of 194This company -$171.2M Sector average $470.6M
▼
-136.4% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 1418.5% year-over-year.
- Ranks #138 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$171.2M | -1418.5% |
| FY2024 | $13.0M | +121.8% |
| FY2023 | -$59.4M | -237.4% |
| FY2022 | -$17.6M | +0.0% |
| FY2021 | -$17.6M | +45.1% |
| FY2020 | -$32.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026